CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicentre Randomised Clinical Trial of Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01298076
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:54.755900+00:00
Published At: 2015-06-03T00:00:00+00:00
Record Updated At: 2015-06-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Diabetic Retinopathy", "Macular Edema"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-06-03"
protocolSection.identificationModule.nctId: "NCT01298076"
protocolSection.identificationModule.officialTitle: "A Multicentre Randomised Clinical Trial of Intravitreal Bevacizumab (Avastin\u00ae) Versus Intravitreal Dexamethasone (Ozurdex\u2122) for Persistent Diabetic Macular Oedema"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.